KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Capital Expenditures (2018 - 2025)

Historic Capital Expenditures for Progyny (PGNY) over the last 8 years, with Q3 2025 value amounting to $4.7 million.

  • Progyny's Capital Expenditures rose 16109.25% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.7 million, marking a year-over-year increase of 25053.69%. This contributed to the annual value of $5.4 million for FY2024, which is 4832.6% up from last year.
  • Latest data reveals that Progyny reported Capital Expenditures of $4.7 million as of Q3 2025, which was up 16109.25% from $5.3 million recorded in Q2 2025.
  • Progyny's Capital Expenditures' 5-year high stood at $5.3 million during Q2 2025, with a 5-year trough of $369000.0 in Q1 2021.
  • Moreover, its 5-year median value for Capital Expenditures was $850000.0 (2024), whereas its average is $1.4 million.
  • Within the past 5 years, the most significant YoY rise in Progyny's Capital Expenditures was 53092.78% (2021), while the steepest drop was 4675.32% (2021).
  • Quarter analysis of 5 years shows Progyny's Capital Expenditures stood at $612000.0 in 2021, then rose by 17.81% to $721000.0 in 2022, then dropped by 5.55% to $681000.0 in 2023, then surged by 178.27% to $1.9 million in 2024, then skyrocketed by 147.18% to $4.7 million in 2025.
  • Its Capital Expenditures was $4.7 million in Q3 2025, compared to $5.3 million in Q2 2025 and $2.8 million in Q1 2025.